|
BR112020007884A2
|
|
method of providing safe administration of adenoviral vectors that encode a Zika virus antigen
|
|
WO2016126659A1
|
|
Magnetic resonance imaging that nulls signals from two or more tissues to better delineate an interested tissue
|
|
WO2016089950A1
|
|
Cancer therapy targeting intercellular adhesion molecule 4 (icam4)
|
|
WO2016061450A1
|
|
Collagen-alginate constructs and uses thereof
|
|
WO2016011268A1
|
|
Atra for modulating pin1 activity and stability
|
|
WO2015168416A1
|
|
Methods for determination of bioactivity, removal, or inactivation cereal amylase trypsin inhibitors in cereals, flours and complex foods
|
|
WO2015143190A1
|
|
Enhanced atra-related compounds derived from structure-activity relationships and modeling for inhibiting pin1
|
|
WO2015074010A2
|
|
Compositions and methods for cardiac regeneration
|
|
KR20150111259A
|
|
Mri methods and apparatus for flexible visualization of any subset of an enlarged temporal window
|
|
WO2015066296A1
|
|
Near-infrared fluorescent nerve contrast agents and methods of use thereof
|
|
WO2015051270A1
|
|
Stabilized human immunodeficiency virus (hiv) clade c envelope (env) trimer vaccines and methods of using same
|
|
EP3049085A1
|
|
Inhibition of sgk1 in the treatment of heart conditions
|
|
US2015079590A1
|
|
Characterization and analysis of the composition and dynamics of the mammalian riboproteome
|
|
WO2015034812A2
|
|
A new ketogenic diet and its use in treating the critically ill
|
|
WO2014186649A2
|
|
Compositions and methods for treating hiv-1-associated chronic immune activation
|
|
WO2014169135A2
|
|
Laparoscopic suction device and method
|
|
WO2014145683A1
|
|
Diabetes treatment
|
|
CN105283196A
|
|
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2014144777A2
|
|
Lipids that increase insulin sensitivity and methods of using the same
|
|
WO2014151596A2
|
|
System and method for inhomogeneous magnetization transfer magnetic resonance imaging
|
